Sight Sciences, Inc. (SGHT)
USD 2.23
(-0.89%)
USD 2.23
(-0.89%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -49.41 Million USD | 30.67% |
| 2022 | -80.47 Million USD | -39.93% |
| 2021 | -57.2 Million USD | -84.39% |
| 2020 | -31.67 Million USD | -34.19% |
| 2019 | -23.46 Million USD | -65.85% |
| 2018 | -14.23 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -14.53 Million USD | -62.51% |
| 2024 Q2 | -12.55 Million USD | 25.48% |
| 2023 Q2 | -13.39 Million USD | 15.09% |
| 2023 Q1 | -15.77 Million USD | -0.66% |
| 2023 FY | - USD | 30.67% |
| 2023 Q4 | -10.92 Million USD | 5.25% |
| 2023 Q3 | -11.52 Million USD | 13.97% |
| 2022 Q3 | -20.89 Million USD | 7.42% |
| 2022 Q2 | -22.57 Million USD | -2.47% |
| 2022 FY | - USD | -39.93% |
| 2022 Q1 | -22.02 Million USD | -49.25% |
| 2022 Q4 | -15.67 Million USD | 24.99% |
| 2021 Q1 | -10.96 Million USD | -31.76% |
| 2021 Q4 | -14.76 Million USD | 4.25% |
| 2021 Q3 | -15.41 Million USD | 5.76% |
| 2021 Q2 | -16.35 Million USD | -49.12% |
| 2021 FY | - USD | -84.39% |
| 2020 FY | - USD | -34.19% |
| 2020 Q3 | -7 Million USD | 8.0% |
| 2020 Q2 | -7.61 Million USD | 9.86% |
| 2020 Q1 | -8.44 Million USD | 0.0% |
| 2020 Q4 | -8.32 Million USD | -18.81% |
| 2019 FY | - USD | -65.85% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -266.39% |
| Cerus Corporation | -26.53 Million USD | -86.219% |
| OrthoPediatrics Corp. | -8.38 Million USD | -489.607% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -370.866% |
| Talis Biomedical Corporation | -66.04 Million USD | 25.18% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -196.342% |
| Inogen, Inc. | -45.67 Million USD | -8.179% |
| Spectral AI, Inc. | -12.26 Million USD | -302.993% |
| Nano-X Imaging Ltd. | -47.69 Million USD | -3.611% |
| CVRx, Inc. | -38.73 Million USD | -27.585% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1300.652% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -308.152% |
| Orthofix Medical Inc. | -86.98 Million USD | 43.191% |
| Venus Concept Inc. | -26.11 Million USD | -89.235% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 0.715% |
| Bioventus Inc. | -23.07 Million USD | -114.196% |
| BrainsWay Ltd. | -2.31 Million USD | -2038.252% |
| Envoy Medical, Inc. | -18.23 Million USD | -170.945% |
| electroCore, Inc. | -17.76 Million USD | -178.238% |
| IceCure Medical Ltd | -15.25 Million USD | -223.969% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 0.675% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -193.165% |
| MaxCyte, Inc. | -44.12 Million USD | -11.981% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -320.339% |
| Nexalin Technology, Inc. | -5.69 Million USD | -768.142% |
| PAVmed Inc | -75.74 Million USD | 34.759% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 8.079% |
| RxSight, Inc. | -41.03 Million USD | -20.416% |
| SI-BONE, Inc. | -34.44 Million USD | -43.456% |
| TELA Bio, Inc. | -40.63 Million USD | -21.613% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 15.237% |
| Treace Medical Concepts, Inc. | -39 Million USD | -26.679% |
| LivaNova PLC | 39.01 Million USD | 226.653% |
| 908 Devices Inc. | -34.02 Million USD | -45.231% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 55.318% |
| Nemaura Medical Inc. | -7.28 Million USD | -578.12% |
| NeuroPace, Inc. | -22.83 Million USD | -116.41% |
| LENSAR, Inc. | -8.71 Million USD | -467.076% |
| Apyx Medical Corporation | -18.11 Million USD | -172.83% |
| Cutera, Inc. | -136.56 Million USD | 63.815% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -1361.982% |
| BioSig Technologies, Inc. | -28.15 Million USD | -75.536% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 2064.03% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -135.433% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 112.883% |
| Axonics, Inc. | 7.77 Million USD | 735.563% |
| Outset Medical, Inc. | -153.78 Million USD | 67.868% |
| IRIDEX Corporation | -7.44 Million USD | -563.467% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 49.625% |
| IRadimed Corporation | 20.8 Million USD | 337.565% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -512.937% |
| INVO Bioscience, Inc. | -6.88 Million USD | -618.239% |
| Telesis Bio, Inc. | -40.49 Million USD | -22.033% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 234.73% |
| Varex Imaging Corporation | 67.2 Million USD | 173.534% |
| Quipt Home Medical Corp. | 44.07 Million USD | 212.126% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -354.6% |
| Pulmonx Corporation | -55.09 Million USD | 10.305% |
| Dynatronics Corporation | -976 Thousand USD | -4962.971% |
| Modular Medical, Inc. | -17.1 Million USD | -188.926% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -241.146% |
| Semler Scientific, Inc. | 23.58 Million USD | 309.483% |
| InMode Ltd. | 196.28 Million USD | 125.175% |
| Bruker Corporation | 599 Million USD | 108.25% |
| Cytosorbents Corporation | -28.81 Million USD | -71.515% |
| DexCom, Inc. | 916.7 Million USD | 105.391% |
| Align Technology, Inc. | 799.03 Million USD | 106.184% |
| Viveve Medical, Inc. | -20.61 Million USD | -139.681% |
| ZimVie Inc. | 91.07 Million USD | 154.259% |
| Movano Inc. | -29.12 Million USD | -69.665% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -1021.03% |
| Nexalin Technology, Inc. | -5.69 Million USD | -768.142% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1300.652% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 74.614% |
| Profound Medical Corp. | -27.12 Million USD | -82.185% |
| Insulet Corporation | 323.6 Million USD | 115.27% |
| enVVeno Medical Corporation | -25.01 Million USD | -97.518% |
| Surmodics, Inc. | 1.18 Million USD | 4259.512% |
| iCAD, Inc. | -6.56 Million USD | -652.704% |
| Nuwellis, Inc. | -16.35 Million USD | -202.122% |
| Biotricity, Inc. | -8.82 Million USD | -459.736% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 48.984% |
| Aethlon Medical, Inc. | -11.84 Million USD | -317.035% |
| InspireMD, Inc. | -20.91 Million USD | -136.311% |
| PAVmed Inc. | -75.74 Million USD | 34.759% |
| BIOLASE, Inc. | -15.13 Million USD | -226.409% |
| Beyond Air, Inc. | -59.03 Million USD | 16.29% |
| FONAR Corporation | 28.25 Million USD | 274.911% |
| AxoGen, Inc. | -13.32 Million USD | -270.761% |
| Vivani Medical, Inc. | -26.6 Million USD | -85.715% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 301.357% |
| Inari Medical, Inc. | 7.11 Million USD | 794.714% |
| UFP Technologies, Inc. | 72.74 Million USD | 167.931% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -1359.484% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -702.713% |
| Tenon Medical, Inc. | -15.52 Million USD | -218.232% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -223.693% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -19.142% |
| AdaptHealth Corp. | -171.09 Million USD | 71.118% |
| Sintx Technologies, Inc. | -6.6 Million USD | -648.712% |
| NanoVibronix, Inc. | -3.43 Million USD | -1338.574% |
| Quanterix Corporation | -38.08 Million USD | -29.739% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -354.6% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 164816.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 82.179% |
| TransMedics Group, Inc. | -7.6 Million USD | -549.941% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -127.039% |
| NeuroMetrix, Inc. | -7.09 Million USD | -596.397% |
| Hyperfine, Inc. | -47.06 Million USD | -5.002% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 15.25% |
| Biomerica, Inc. | -5.99 Million USD | -724.545% |
| Bone Biologics Corporation | 479.57 Thousand USD | 10403.979% |
| AVITA Medical, Inc. | -39.56 Million USD | -24.887% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -438.705% |
| Silk Road Medical, Inc | -45.08 Million USD | -9.616% |